Phase-3 programs consisting of six or more trials are becoming increasingly commonplace. Yet another reason it requires so much R&D money, on average, to get one drug approved.
REGN/SNY—If ODYSSEY OUTCOMES by itself will cost $500M (#msg-81212052), how much will the suite of approximately six phase-3 trials for REGN727 announced in #msg-73969663 cost?
Market Data 
Markets 
AI
